CTRI/2023/06/053767Not yet recruitingPhase 3
Optimizing duration of anticoagulation following acute venous thromboembolism (VTE) by assessing residual venous thrombosis by ultrasound â?? a multicenter randomized controlled trial
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Adults >18 years diagnosed with acute lower limb DVT with or without associated pulmonary
Exclusion Criteria
- •1.Previous VTE
- •2.Any indication for lifelong anticoagulation
- •3.Contraindications for anticoagulation
- •4.Active malignancy
- •5.Pregnancy
Investigators
Similar Trials
Recruiting
Phase 4
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients with CancerPulmonary embolismJPRN-jRCTs051200135Ono Koh330
Recruiting
Not Applicable
Optimal Duration of antiplatelet Therapy after Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic EventsKCT0002908Asan Medical Center2,000
Not yet recruiting
Not Applicable
Target Activated Clotting time for anticoagulation during cardiopulmonary bypassNL-OMON27592niversity Medical Center Utrecht1,536
Recruiting
Not Applicable
Appropriate Duration of Anti-Platelet straTegy in patients with advance Chronic Kideny Disease after new generation drug eluting stents (ADAPT-CKD)KCT0005775Yonsei University Health System, Severance Hospital900
Recruiting
Not Applicable
Target Activated Clotting Time for anticoagulation during cardiopulmonary bypassNL-OMON52711Perfusie1,010